NCT01305356 Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions Status COMPLETED Phase NA
NCT01303874 Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) Status COMPLETED Phase PHASE4
NCT01301703 Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis Status UNKNOWN Phase PHASE4
NCT01299961 Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01299545 Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy Status TERMINATED Phase N/A
NCT01296711 Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056 Status TERMINATED Phase PHASE2
NCT01295151 SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. Status COMPLETED Phase PHASE4
NCT01294722 A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea Status COMPLETED Phase N/A
NCT01294397 Effects of Denosumab on the Pharmacokinetics of Etanercept Status TERMINATED Phase PHASE1
NCT01292616 Effect of TNF-Inhibition Combined With Conventional DMARDs on Cervical Pannus in Patients With RA and Cervical Spine Involvement Status UNKNOWN Phase N/A
NCT01292265 A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA) Status TERMINATED Phase PHASE3
NCT01287858 Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01287533 Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids Status COMPLETED Phase PHASE4
NCT01285752 A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT01285336 The Genetic and the Functional Study of DNA Repair System and the Susceptibility to Rheumatoid Arthritis Status COMPLETED Phase NA
NCT01285310 Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT01284569 Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01284283 2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use Status COMPLETED Phase NA
NCT01283971 A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor Status TERMINATED Phase PHASE4
NCT01283399 An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis Status COMPLETED Phase N/A